Krista L. Namminga

620 total citations
12 papers, 397 citations indexed

About

Krista L. Namminga is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Krista L. Namminga has authored 12 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Krista L. Namminga's work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Nerve injury and regeneration (4 papers). Krista L. Namminga is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Nerve injury and regeneration (4 papers). Krista L. Namminga collaborates with scholars based in United States, Egypt and United Kingdom. Krista L. Namminga's co-authors include R. Lee Mosley, Howard E. Gendelman, Katherine E. Olson, Yaman Lu, Jatin Machhi, Aaron Schwab, Mai Mohamed Abdelmoaty, Pravin Yeapuri, Larisa Y. Poluektova and Yutong Liu and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Neurobiology of Disease.

In The Last Decade

Krista L. Namminga

12 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krista L. Namminga United States 10 229 128 114 99 92 12 397
Chris-Anne McKenzie United Kingdom 10 112 0.5× 76 0.6× 173 1.5× 114 1.2× 177 1.9× 12 461
Walther Haenseler United Kingdom 7 331 1.4× 187 1.5× 146 1.3× 167 1.7× 265 2.9× 10 682
Russell J. Swan United States 13 262 1.1× 34 0.3× 255 2.2× 97 1.0× 149 1.6× 18 702
Georg Werner Germany 8 365 1.6× 144 1.1× 260 2.3× 43 0.4× 113 1.2× 10 606
Michael J. Vasek United States 10 172 0.8× 52 0.4× 86 0.8× 135 1.4× 220 2.4× 11 505
Paula R. Sola Brazil 5 423 1.8× 31 0.2× 136 1.2× 63 0.6× 130 1.4× 8 545
Romina Aron-Badin France 5 162 0.7× 123 1.0× 93 0.8× 181 1.8× 105 1.1× 6 417
Anthony Fernández-Castañeda United States 7 99 0.4× 69 0.5× 36 0.3× 79 0.8× 238 2.6× 8 495
David H. Allendorf United Kingdom 9 332 1.4× 38 0.3× 125 1.1× 44 0.4× 244 2.7× 10 606

Countries citing papers authored by Krista L. Namminga

Since Specialization
Citations

This map shows the geographic impact of Krista L. Namminga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krista L. Namminga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krista L. Namminga more than expected).

Fields of papers citing papers by Krista L. Namminga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krista L. Namminga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krista L. Namminga. The network helps show where Krista L. Namminga may publish in the future.

Co-authorship network of co-authors of Krista L. Namminga

This figure shows the co-authorship network connecting the top 25 collaborators of Krista L. Namminga. A scholar is included among the top collaborators of Krista L. Namminga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krista L. Namminga. Krista L. Namminga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Olson, Katherine E., Mai Mohamed Abdelmoaty, Krista L. Namminga, et al.. (2023). An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers. Translational Neurodegeneration. 12(1). 26–26. 16 indexed citations
2.
Yeapuri, Pravin, Jatin Machhi, Yaman Lu, et al.. (2023). Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice. Molecular Neurodegeneration. 18(1). 97–97. 36 indexed citations
3.
Abdelmoaty, Mai Mohamed, Pravin Yeapuri, Jatin Machhi, et al.. (2023). Immune senescence in aged APP/PS1 mice. PubMed. 2(3). 317–330. 4 indexed citations
4.
Yeapuri, Pravin, Katherine E. Olson, Yaman Lu, et al.. (2022). Development of an extended half-life GM-CSF fusion protein for Parkinson's disease. Journal of Controlled Release. 348. 951–965. 19 indexed citations
5.
Marković, Milica, Pravin Yeapuri, Krista L. Namminga, et al.. (2022). Interleukin-2 expands neuroprotective regulatory T cells in Parkinson’s disease. PubMed. 1(1). 43–50. 8 indexed citations
6.
Machhi, Jatin, Pravin Yeapuri, Yaman Lu, et al.. (2021). CD4+ effector T cells accelerate Alzheimer’s disease in mice. Journal of Neuroinflammation. 18(1). 272–272. 96 indexed citations
7.
Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease. Biomaterials. 272. 120786–120786. 38 indexed citations
8.
Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease. EBioMedicine. 67. 103380–103380. 35 indexed citations
9.
Schwab, Aaron, Jatin Machhi, Katherine E. Olson, et al.. (2020). Immunotherapy for Parkinson’s disease. Neurobiology of Disease. 137. 104760–104760. 68 indexed citations
10.
Olson, Katherine E., Krista L. Namminga, Aaron Schwab, et al.. (2020). Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice. Neurotherapeutics. 17(4). 1861–1877. 25 indexed citations
11.
Mosley, R. Lee, Yaman Lu, Katherine E. Olson, et al.. (2019). A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease. Frontiers in Cellular Neuroscience. 13. 38 indexed citations
12.
Olson, Katherine E., Aditya N. Bade, Krista L. Namminga, et al.. (2018). Persistent EcoHIV infection induces nigral degeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice. Journal of NeuroVirology. 24(4). 398–410. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026